Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 456,303
  • Shares Outstanding, K 103,470
  • Annual Sales, $ 39,280 K
  • Annual Income, $ -62,910 K
  • 36-Month Beta 1.84
  • Price/Sales 12.15
  • Price/Cash Flow 0.00
  • Price/Book 8.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.03 +9.43%
on 04/06/17
4.70 -6.17%
on 04/26/17
+0.19 (+4.50%)
since 03/27/17
3-Month
3.79 +16.36%
on 03/09/17
4.70 -6.17%
on 04/26/17
+0.15 (+3.52%)
since 01/27/17
52-Week
3.79 +16.36%
on 03/09/17
7.64 -42.28%
on 08/01/16
-2.06 (-31.84%)
since 04/27/16

Most Recent Stories

More News
Cerus to Release First Quarter 2017 Results on May 3, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Wednesday, May 3, 2017, after the close of the stock market. The company will host a conference...

CERS : 4.41 (-4.34%)
Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ:CERS) announced today that, on April 3, 2017, the compensation committee of the company's board of directors granted 21 new non-executive employees options to purchase...

CERS : 4.41 (-4.34%)
Cerus Corporation Reports Fourth Quarter and Year End 2016 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2016.

CERS : 4.41 (-4.34%)
Cerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2016 will be released on Tuesday, March 7, 2017, after the close of the stock market. The...

CERS : 4.41 (-4.34%)
Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus

This morning, Stock-Callers.com puts focus on select equities to see how they have fared over the last few trading sessions: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), Tesaro Inc. (NASDAQ: TSRO), Sangamo...

SGMO : 4.90 (-2.00%)
TSRO : 146.61 (+3.24%)
PTLA : 39.64 (+2.24%)
CERS : 4.41 (-4.34%)
Cerus Corporate and Operational Update

(via TheNewswire)

CEA.VN : 0.070 (-12.50%)
CERS : 4.41 (-4.34%)
PSCSF : 0.0418 (+318.00%)
Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Aralez Pharma, Cerus, and Pain Therapeutics

Stock-Callers.com has issued research reports on four Biotech equities, which are Pacific Biosciences of California Inc. (NASDAQ: PACB), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), Cerus Corp. (NASDAQ:...

ARLZ : 1.63 (-3.55%)
PACB : 4.05 (-21.81%)
PTIE : 0.79 (unch)
CERS : 4.41 (-4.34%)
Is Cerus (CERS) Stock a Solid Choice Right Now?

Cerus (CERS) is seeing solid earnings estimate revision and is well-positioned from a Zacks Industry Rank perspective.

CERS : 4.41 (-4.34%)
Cerus Down 21.2% Since SmarTrend Downtrend Call (CERS)

SmarTrend identified a Downtrend for Cerus (NASDAQ:CERS) on September 1st, 2016 at $6.37. In approximately 2 months, Cerus has returned 21.19% as of today's recent price of $5.02.

CERS : 4.41 (-4.34%)
Cerus Corporation Reports Third Quarter 2016 Results

Cerus Corporation (NASDAQ: CERS) today announced financial results for the third quarter ended September 30, 2016.

CERS : 4.41 (-4.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Support & Resistance

2nd Resistance Point 4.79
1st Resistance Point 4.60
Last Price 4.41
1st Support Level 4.31
2nd Support Level 4.21

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.